Introduction
(-)-Spicigerolide (1) belongs to a family of polyacetate pyranone-containing natural products which exhibit a broad spectrum of pharmacological properties (Figure 1) . 1 These polyoxygenated 6-heptenyl-5,6-dihydro-α-pyrones have been found in several species of the genus Hyptis and other related genera. 2, 3 In particular, spicigerolide has been isolated from Hyptis spicigera, a plant that is used in traditional Mexican medicine to treat gastrointestinal disturbances, skin infections, wounds and insects bites. The Michael acceptor moiety present in all these molecules potentially endows them with cytotoxic properties. Indeed, spicigerolide and some of its stereoisomers have shown cytotoxic activity in some cell tumoral lines. 1, 4 Due to their biological activity, several stereoselective approaches have already been applied to this group of polyoxygenated compounds. Thus, syntheses of (+)-anamarine (2), 5 (-)-anamarine, 6 and spicigerolide (1) 1 have been described from carbohydrates. In contrast, the synthesis of (+)-hyptolide (3) 7 is based on carbonyl additions, and there are alternate approaches to (+)-anamarine (2) which exploit asymmetric dihydroxylation 8 or aldol reactions. As a part of our work on the stereocontrolled construction of sugar-type polyhydroxylated frameworks, 10 we have explored a novel synthetic approach to these polyacetylated lactones.
Specifically, we focused on the synthesis of the (-)-spicigerolide (1) as a representative example of this class of compounds. We envisaged that our recently reported methodology 10a could be applied easily to the synthesis of 1. In contrast to the previous synthesis, 1b,c our strategy creates the stereocentres independently rather than to rely on carbohydrates as chiral starting materials (Scheme 1). 
Scheme 1
Analysis of the structure of (-)-spicigerolide prompted us to consider that the pyranone could be obtained by selective olefin ring-closing metathesis (RCM) of the homoallyl acrylate 6, which in turn, could be prepared via asymmetric allylation of aldehyde 7 followed by acylation (Scheme 2). Regarding the remaining polyoxygenated chain, we tried to minimize the use of protecting groups by maintaining the oxygenated functional groups as acetates and using only silicon-derived protecting groups for transient protections. Thus, the α,β-unsaturated aldehyde 7 could arise from the related alkynol 8 obtained by stereoselective alkynylation of aldehyde 9 with a protected 2-propyn-1-ol. 
Scheme 2
We considered that the key aldehyde 9 could be prepared from the protected (S)-lactaldehyde 10 and propargylic acetate 11 via our stereoselective approach to polyhydroxylated arrays. 10a Therefore, we had to combine two stereoselective reactions: (i) Carreira's asymmetric alkynylation of aldehydes 11 with propargylic esters 12 and (ii) stereoselective [3, 3] 
Results and Discussion
As expected, (R)-1-phenylprop-2-ynyl acetate (R)-11 reacted with aldehyde 10 under Carreira's conditions 11 mediated by (-)-N-methylephedrine ((-)-NME) to afford anti,syn-12 in 95% yield as a single stereoisomer. The configuration of the alkyne 11 did not affect the diastereomeric ratio. 
Scheme 4
Treatment of anti,syn-12 with LiAlH 4 reduced the triple bond to an E-alkene with concomitant alcohol deprotection leading to a triol (13) which was acetylated in situ with acetic anhydride to form the triacetate 14 in 87% yield for the two steps (Scheme 5). Having achieved the right stereochemistry at C-2 and C-3 in 14, we next attempted to transfer the chirality from C-6 to C-4 by a Pd-catalyzed [3, 3] 
Scheme 5
The key aldehyde 9 was obtained by ozonolysis followed by treatment with Me 2 S. This unstable aldehyde was immediately submitted to Carreira's asymmetric alkynylation with 2-tertbutyldiphenylsilyloxy-1-propyne (16) mediated by (+)-N-methylephedrine. Unfortunately, aldehyde 9
did not react efficiently under the standard Carreira's conditions; instead, three equivalents of alkyne 16, zinc triflate, (+)-NME and triethylamine were required to achieve good yields. 15 Under these conditions, partial acetyl deprotection was observed. Therefore, the crude mixture was acetylated again to afford tetraacetate 8 in 71% yield (for three steps) and as a single diastereoisomer. 
Scheme 6
We then focused on assembling the pyranone ring. Swern oxidation of alcohol 18 afforded aldehyde 7 (Scheme 7). Stereoselective allylation of 7 was initially attempted with (Ipc) 2 B-allyl without success. 16 However, Duthaler's Ti-TADDOL mediated allylation 17 with 19 provided the expected homoallylic alcohol 20 in good yield (84%) as a separable diastereomeric mixture (87:13). Acylation of alcohol 20 with acryloyl chloride followed by RCM 18 in the presence of the second-generation Grubbs' ruthenium catalyst (21, 2% mol) afforded the (-)-spicigerolide (1), whose spectroscopic data was identical to that of the natural product. 
Conclusion
We have reported an enantioselective synthesis of (-)-spicigerolide (1) which features independent stereocontrolled access to the different chiral centers. It constitutes the first application to natural product synthesis of our recently developed strategy for building polyhydroxylated chains, which is based on Pd(II) [3, 3] -sigmatropic rearrangements and Carreira's alkynylations. Furthermore, we were able to shorten the sequence by minimizing the use of protecting groups.
Experimental Section
(1S,4R,5S)-5-tert-Butyldiphenylsilyloxy-4-hydroxy-1-phenylhex-2-ynyl acetate (anti,syn-12).
Zn(OTf) 2 (2.4 g, 6.6 mmol) was heated under vacuum in a flask. (-)-NME (1.3 g, 7.2 mmol) was added, and the flask was purged with nitrogen. Anhydrous toluene (10 mL) and Et 3 N (1.0 mL, 7.2 mmol) were added and the mixture was stirred at rt for 2 h 30 min. A solution of alkyne (R)-11 (1.04 g, 6.00 mmol)
in toluene (5 mL) was added and stirred at rt for 30 min. Then, a solution of (S)-2-tertbutyldiphenylsilyloxypropanal (10, 2.25 mg, 7.20 mmol) in toluene (5 mL 6, 136.8, 135.9, 135.7, 133.5, 133.4, 129.9, 129.8, 128.9, 128.6, 127.8, 127.7, 127.6, 85.1, 82.6, 72.1, 67.3, 65.5, 26.9, 21.0, 19.3, 18.4 3, 170.1, 169.9, 135.8, 134.9, 128.6, 128.4, 126.7, 122.7, 74.1, 72.2, 67.9, 21.0, 21.0, 20.8, 15.4; HMRS (ESI+) 67.1, 61. 5, 52.5, 26.6, 21.0, 20.7, 20.7, 20.6, 19.1, 16.4 0, 170.0, 169.8, 169.4, 136.6, 135.6, 135.5, 133.5, 133.4, 129.7, 127.7, 124.1, 71.0, 69.7, 67.0, 66.3, 60.2, 26.7, 21.0, 20.9, 20.6, 20.6, 19.1, 16.6; HMRS (ESI+) 4, 170.1, 170.1, 169.8, 135.8, 125.2, 71.2, 69.7, 67.0, 66.8, 58.5, 21.0, 21.0, 20.7, 20.6, 16. 4, 170.3, 169.9, 169.9, 139.1, 133.8, 123.8, 118.1, 71.2, 69.9, 67.3, 67.2, 67.1, 41.4, 21.0, 20.9, 20.8, 20.7, 15.8 3, 170.1, 170.0, 169.5, 164.8, 134.5, 132.8, 130.6, 128.7, 127.4, 118.2, 71.0, 69.6, 69.2, 66.9, 66.6, 39.0, 21.1, 20.9, 20.7, 20.6, 16.6; HMRS (ESI+) 
